LIDOX | VIHAX | LIDOX / VIHAX | |
Total Expense Ratio | 0.66 | 0.17 | 388% |
Annual Report Gross Expense Ratio | 0.66 | 0.17 | 388% |
Fund Existence | 8 years | 9 years | - |
Gain YTD | 27.143 | 24.826 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 469M | 11.9B | 4% |
Annual Yield % from dividends | 3.12 | 4.18 | 74% |
Returns for 1 year | 23.56 | 21.38 | 110% |
Returns for 3 years | 56.97 | 43.74 | 130% |
Returns for 5 years | 70.75 | 62.75 | 113% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSCH | 40.10 | 0.26 | +0.66% |
Invesco S&P SmallCap Health Care ETF | |||
EPOL | 33.45 | 0.18 | +0.54% |
iShares MSCI Poland ETF | |||
BBEU | 68.72 | 0.22 | +0.32% |
JPMorgan BetaBuilders Europe ETF | |||
JMID | 29.33 | -0.17 | -0.59% |
Janus Henderson Mid Cap Growth Alpha ETF | |||
SQLV | 41.85 | -0.85 | -1.99% |
Royce Quant Small-Cap Quality Value ETF |